Clinical Trial Update: Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 clinical trial evaluating the safety and effectiveness of PRI-724 in patients with cirrhosis due to Hepatitis C or Hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Hepatitis C
• Liver Cirrhosis

Drugs mentioned

• PRI-724 (PRI-724)

Snippet

Sponsor: Kiminori Kimura, MD | Conditions: Hepatitis C, Hepatitis B | Phase 1, Phase 2 | Status: COMPLETED